13-07-2023 08:00 via wallstreet-online.de

XVIVO Presents Interim Report January-June 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) "Continued momentum for our business"Second quarter 2023 (Apr 1 - Jun 30)• Net sales amounted to SEK 154.6 million (94.3), corresponding to an …
Weiterlesen »